Quick Take: Mind Medicine (MindMed) Inc. are now commencing clinical trials combining MDMA and LSD The Phase 1 MDMA-LSD trials are scheduled to start in Q4 of 2020 These trials are expected to take one year to complete NEW YORK, Aug. 25, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (MMED)(OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired…